Azvudine efficacy in reducing mortality in COVID-19 patients
Abstract Background Several therapeutic drugs have been authorized for the treatment of patients with Coronavirus disease 2019 (COVID-19). However, further research on the mechanisms of action, efficacy, and target populations of these novel therapeutic drugs are necessary. This study included mild,...
Saved in:
| Main Authors: | Zhen Zhong, Xiao-feng Liu, Xiao-zhong Zhou, Jia-ning Zhong, Li-cheng Zhou, Rong Li, Xian-fa Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | European Journal of Medical Research |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40001-024-02220-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of azvudine plus dexamethasone in severe hospitalized patients with Omicron infection: a prospective multicenter study
by: Meng-Lan Zhang, et al.
Published: (2024-11-01) -
Comparison of the therapeutic effect of Paxlovid and Azvudine in the treatment of COVID-19: A retrospective study
by: Wei Yang, et al.
Published: (2024-12-01) -
Immunophenotyping characteristics and clinical outcome of COVID-19 patients treated with azvudine during the Omicron surge
by: Meihua Qiu, et al.
Published: (2024-11-01) -
Safety of Antiplatelet Therapy in Noncardioembolic Ischemic Stroke With Thrombocytopenia: The CASE II Study
by: Dongjuan Xu, et al.
Published: (2024-08-01) -
Real-world studies of crizotinib in patients with ROS1-positive non-small-cell lung cancer: experience from China
by: Hua Zhong, et al.
Published: (2024-12-01)